Prescott Group Capital Management L.L.C. Takes Position in Acadia Healthcare Company, Inc. $ACHC

Prescott Group Capital Management L.L.C. acquired a new stake in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 200,000 shares of the company’s stock, valued at approximately $2,838,000. Prescott Group Capital Management L.L.C. owned about 0.22% of Acadia Healthcare at the end of the most recent reporting period.

A number of other institutional investors have also modified their holdings of the company. Wellington Management Group LLP raised its position in shares of Acadia Healthcare by 11.8% in the third quarter. Wellington Management Group LLP now owns 9,423,548 shares of the company’s stock valued at $233,327,000 after buying an additional 993,205 shares during the last quarter. Vanguard Group Inc. grew its holdings in Acadia Healthcare by 7.8% in the third quarter. Vanguard Group Inc. now owns 9,417,045 shares of the company’s stock valued at $233,166,000 after purchasing an additional 681,278 shares during the period. Abrams Bison Investments LLC grew its holdings in Acadia Healthcare by 22.3% in the third quarter. Abrams Bison Investments LLC now owns 4,380,000 shares of the company’s stock valued at $108,449,000 after purchasing an additional 800,000 shares during the period. UBS Group AG grew its holdings in Acadia Healthcare by 8.8% in the third quarter. UBS Group AG now owns 4,336,698 shares of the company’s stock valued at $107,377,000 after purchasing an additional 350,484 shares during the period. Finally, State Street Corp grew its holdings in Acadia Healthcare by 3.2% in the second quarter. State Street Corp now owns 3,095,775 shares of the company’s stock valued at $70,243,000 after purchasing an additional 95,670 shares during the period.

Analyst Ratings Changes

ACHC has been the subject of a number of recent analyst reports. Zacks Research upgraded shares of Acadia Healthcare from a “strong sell” rating to a “hold” rating in a report on Thursday, March 5th. UBS Group boosted their target price on shares of Acadia Healthcare from $27.00 to $31.00 and gave the company a “buy” rating in a report on Friday, April 17th. Cantor Fitzgerald boosted their target price on shares of Acadia Healthcare from $20.00 to $30.00 and gave the company a “neutral” rating in a report on Friday, May 1st. Royal Bank Of Canada boosted their target price on shares of Acadia Healthcare from $28.00 to $31.00 and gave the company an “outperform” rating in a report on Monday, May 4th. Finally, Barclays boosted their target price on shares of Acadia Healthcare from $20.00 to $25.00 and gave the company an “equal weight” rating in a report on Thursday, April 30th. One investment analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating, seven have assigned a Hold rating and two have given a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $26.04.

Acadia Healthcare Price Performance

ACHC opened at $24.07 on Thursday. The company has a quick ratio of 1.71, a current ratio of 1.71 and a debt-to-equity ratio of 1.27. Acadia Healthcare Company, Inc. has a 52-week low of $11.43 and a 52-week high of $30.20. The company has a 50 day moving average of $25.27 and a two-hundred day moving average of $19.28. The company has a market cap of $2.21 billion, a P/E ratio of -1.97, a P/E/G ratio of 8.38 and a beta of 0.73.

Acadia Healthcare (NASDAQ:ACHC) last released its quarterly earnings data on Wednesday, April 29th. The company reported $0.37 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.28 by $0.09. Acadia Healthcare had a negative net margin of 32.84% and a positive return on equity of 7.09%. The company had revenue of $828.80 million during the quarter, compared to the consensus estimate of $823.51 million. During the same period in the previous year, the firm earned $0.40 earnings per share. Acadia Healthcare’s revenue for the quarter was up 7.6% on a year-over-year basis. Acadia Healthcare has set its Q2 2026 guidance at 0.300-0.400 EPS. On average, analysts expect that Acadia Healthcare Company, Inc. will post 1.49 earnings per share for the current year.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.